# mesalamine

NDC: 68382-435
Generic name: mesalamine
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20180802

FDA application: ANDA203286

## Active ingredients

- MESALAMINE: 800 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68382-435"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68382-435
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad8c7930-92e2-4372-a874-da22b9ae333e